Research ExplorerPublicationsFirst-in-human implantation of a novel transfemoral selfexpa...

First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation

Standard

First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation. / Schäfer, Ulrich; Schirmer, Johannes; Niklas, Schofer; Harmel, Eva; Deuschl, Florian; Conradi, Lenard.

In: EUROINTERVENTION, Vol. 13, No. 11, 20.12.2017, p. 1296-1299.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Schäfer, U, Schirmer, J, Niklas, S, Harmel, E, Deuschl, F & Conradi, L 2017, 'First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation', EUROINTERVENTION, vol. 13, no. 11, pp. 1296-1299. https://doi.org/10.4244/EIJ-D-17-00502

APA

Schäfer, U., Schirmer, J., Niklas, S., Harmel, E., Deuschl, F., & Conradi, L. (2017). First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation. EUROINTERVENTION, 13(11), 1296-1299. https://doi.org/10.4244/EIJ-D-17-00502

Vancouver

Schäfer U, Schirmer J, Niklas S, Harmel E, Deuschl F, Conradi L. First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation. EUROINTERVENTION. 2017 Dec 20;13(11):1296-1299. https://doi.org/10.4244/EIJ-D-17-00502

Bibtex

@article{10a7e041d09c405e9485c8f4885f880c,
title = "First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation",
abstract = "Here we will describe the first case of a novel JenaValve design (JenaValve Technology, Irvine, CA, USA) using the transfemoral approach in a 78-year-old female patient with pure aortic regurgitation. The implantation was successfully performed with good haemodynamics and good clinical outcome at six-month follow- up. The technology is especially appealing in non-calcified anatomies due to the clipping mechanism which was previously utilised in the transapical design.",
keywords = "Aged, Aortic Valve/diagnostic imaging, Aortic Valve Insufficiency/diagnostic imaging, Catheterization, Peripheral/adverse effects, Computed Tomography Angiography, Coronary Angiography/methods, Echocardiography, Doppler, Color, Echocardiography, Transesophageal, Female, Femoral Artery/diagnostic imaging, Heart Valve Prosthesis, Hemodynamics, Humans, Multidetector Computed Tomography, Prosthesis Design, Recovery of Function, Transcatheter Aortic Valve Replacement/adverse effects, Treatment Outcome",
author = "Ulrich Sch{\"a}fer and Johannes Schirmer and Schofer Niklas and Eva Harmel and Florian Deuschl and Lenard Conradi",
year = "2017",
month = dec,
day = "20",
doi = "10.4244/EIJ-D-17-00502",
language = "English",
volume = "13",
pages = "1296--1299",
journal = "EUROINTERVENTION",
issn = "1774-024X",
publisher = "EUROPA EDITION",
number = "11",

}

RIS

TY - JOUR

T1 - First-in-human implantation of a novel transfemoral selfexpanding transcatheter heart valve to treat pure aortic regurgitation

AU - Schäfer, Ulrich

AU - Schirmer, Johannes

AU - Niklas, Schofer

AU - Harmel, Eva

AU - Deuschl, Florian

AU - Conradi, Lenard

PY - 2017/12/20

Y1 - 2017/12/20

N2 - Here we will describe the first case of a novel JenaValve design (JenaValve Technology, Irvine, CA, USA) using the transfemoral approach in a 78-year-old female patient with pure aortic regurgitation. The implantation was successfully performed with good haemodynamics and good clinical outcome at six-month follow- up. The technology is especially appealing in non-calcified anatomies due to the clipping mechanism which was previously utilised in the transapical design.

AB - Here we will describe the first case of a novel JenaValve design (JenaValve Technology, Irvine, CA, USA) using the transfemoral approach in a 78-year-old female patient with pure aortic regurgitation. The implantation was successfully performed with good haemodynamics and good clinical outcome at six-month follow- up. The technology is especially appealing in non-calcified anatomies due to the clipping mechanism which was previously utilised in the transapical design.

KW - Aged

KW - Aortic Valve/diagnostic imaging

KW - Aortic Valve Insufficiency/diagnostic imaging

KW - Catheterization, Peripheral/adverse effects

KW - Computed Tomography Angiography

KW - Coronary Angiography/methods

KW - Echocardiography, Doppler, Color

KW - Echocardiography, Transesophageal

KW - Female

KW - Femoral Artery/diagnostic imaging

KW - Heart Valve Prosthesis

KW - Hemodynamics

KW - Humans

KW - Multidetector Computed Tomography

KW - Prosthesis Design

KW - Recovery of Function

KW - Transcatheter Aortic Valve Replacement/adverse effects

KW - Treatment Outcome

U2 - 10.4244/EIJ-D-17-00502

DO - 10.4244/EIJ-D-17-00502

M3 - SCORING: Journal article

C2 - 28846544

VL - 13

SP - 1296

EP - 1299

JO - EUROINTERVENTION

JF - EUROINTERVENTION

SN - 1774-024X

IS - 11

ER -